EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracellular Vesicles, as Drug-Delivery Vehicles, Improve the Biological Activities of Astaxanthin

Young Jun Jang, Byung Seok Cha, Doyeon Kim, Eun Sung Lee, Seokjoon Kim, Jinjoo Han, Jiye Shin, Seokhwan Kim, Ki Soo Park iD

Antioxidants · 13.02.2023 · 12 (2) · 473

DOI: 10.3390/antiox12020473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 13.02.2023. Verfasst von Young Jun Jang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, College of Engineering, Konkuk University, Seoul 05029, Republic of Korea. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Konkuk University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astaxanthin (AST) exhibits potent antioxidant and anti-inflammatory activities but poor stability and biological efficacy, which limit its application in the food and medical industries. In the present study, a new strategy was proposed to enhance the biological activities of AST using fetal bovine serum-derived extracellular vesicles (EVs). Saponin-assisted incubation was used to load AST owing to its high encapsulation efficiency and loading capacity. AST-incorporated EVs (EV-ASTs) maintained their original EV morphology and showed high stability at 4 °C, 25 °C, and 37 °C over a 28-day period, which was attributed to the protective environment provided by the phospholipid bilayer membrane of the EVs. Additionally, the EV-ASTs exhibited excellent antioxidant and anti-inflammatory activities in HaCaT keratinocytes and RAW 264.7 macrophage cells, respectively; these were significantly higher than those of free AST. Furthermore, the mechanism associated with the enhanced biological activities of EV-ASTs was evaluated by analyzing the expression of genes involved in antioxidation and anti-inflammation, in parallel with cellular in vitro assays. These results provide insights into methods for improving the performance of hydrophobic drugs using nature-derived EVs and will contribute to the development of novel drug-delivery systems.

Schlagwörter

Stichwörter der Autor:innen

anti-inflammatory activityantioxidant activityastaxanthin (AST)extracellular vesicles (EVs)saponin

Autor:innen und Institutionen

  • Department of Biological Engineering, College of Engineering, Konkuk University, Seoul 05029, Republic of Korea.

ORCID-Profile: Ki Soo Park

Förderung

  • Konkuk University

Zitieren

APA

Jang, Y. J., Cha, B. S., Kim, D., Lee, E. S., Kim, S., Han, J., Shin, J., Kim, S., & Park, K. S. (2023). Extracellular Vesicles, as Drug-Delivery Vehicles, Improve the Biological Activities of Astaxanthin. Antioxidants, 12(2), 473. https://doi.org/10.3390/antiox12020473

Vancouver

Jang YJ, Cha BS, Kim D, Lee ES, Kim S, Han J, et al. Extracellular Vesicles, as Drug-Delivery Vehicles, Improve the Biological Activities of Astaxanthin. Antioxidants. 2023;12(2):473. doi:10.3390/antiox12020473

BibTeX
@article{Jang2023,
  author = {Jang, Young Jun and Cha, Byung Seok and Kim, Doyeon and Lee, Eun Sung and Kim, Seokjoon and Han, Jinjoo and Shin, Jiye and Kim, Seokhwan and Park, Ki Soo},
  title = {Extracellular Vesicles, as Drug-Delivery Vehicles, Improve the Biological Activities of Astaxanthin},
  journal = {Antioxidants},
  year = {2023},
  volume = {12},
  number = {2},
  pages = {473},
  doi = {10.3390/antiox12020473}
}
Kostenlos starten →